Inter Costal Catheters for Video-Assisted Thoroscopic (VATS) Lobectomy

This study has been completed.
Sponsor:
Collaborators:
Dept. of thoracic Surgery
Dept. of cardio-thoracic anaesthesia
Dept. Surgical PAthophysiology
all Blegdamsvej 9, 2100-Copenhagen, Denmark
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01213654
First received: October 1, 2010
Last updated: NA
Last verified: October 2010
History: No changes posted
  Purpose

A pilot study to observe satisfaction of analgesia with intercostal catheters after VATS lobectomy.


Condition
Lung Cancer Patients

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pain Relief After VATS Lobectomy Using Interoperatively Placed Inter Costal Catheters.

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • NRS (pain score 0-10)) [ Time Frame: Until discharge (2-4 days) ] [ Designated as safety issue: No ]
    Painscore

  • satisfaction (Verbal ranking scale 1-4) [ Time Frame: until discharge, 2-4 days ] [ Designated as safety issue: No ]
    qualitative measurement


Secondary Outcome Measures:
  • Side effects (quantitatively, see details) [ Time Frame: until discharge, 2-4 days ] [ Designated as safety issue: Yes ]
    Daily presence of, Nausea Dizziness Vomiting Sedation Pruritus


Enrollment: 50
Study Start Date: April 2010
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Pain and satisfaction with pain treatment is investigated in a population after VATS lobectomy.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Consenting lung cancer patients due for elective surgery

Criteria

Inclusion Criteria:

Age of consent (ie age>=18) Eligible for lobectomy Able to comply Willing to register postoperatively

-

Exclusion Criteria:

  • do not understand DAnish
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01213654

Locations
Denmark
Rigshospitalet
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Dept. of thoracic Surgery
Dept. of cardio-thoracic anaesthesia
Dept. Surgical PAthophysiology
all Blegdamsvej 9, 2100-Copenhagen, Denmark
  More Information

No publications provided

Responsible Party: MD Kim Wildgaard, Section for Surgical Pathophysiology
ClinicalTrials.gov Identifier: NCT01213654     History of Changes
Other Study ID Numbers: VATS-IC-2010
Study First Received: October 1, 2010
Last Updated: October 1, 2010
Health Authority: Denmark: Danish Board of Health

Keywords provided by Rigshospitalet, Denmark:
Lung cancer
VATS Lobectomy

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on July 28, 2014